Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

NIH State-of-the-Science Conference Statement on preventing violence and related health-risking social behaviors in adolescents.

BIBLIOGRAPHIC SOURCE(S)

GUIDELINE STATUS

This is the current release of the guideline.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

The National Institutes of Health State-of-the-Science Panel highlights the following findings and recommendations:

  • Violence affects all of us at some level and represents an issue of vital national and international importance.
  • Some interventions have been shown by rigorous research to reduce violence precursors, violence, and arrest. However, many interventions aimed at reducing violence have not been sufficiently evaluated or proven effective, and a few widely implemented programs have been shown to be ineffective and perhaps harmful.
  • Programs that seek to prevent violence through fear and tough treatment appear ineffective. Intensive programs that aim at developing skills and competencies can work.
  • Interventions to reduce violence may be context dependent. Research must proceed in varying contexts and take account of local culture.
  • Attention to diversity among investigators involved in violence prevention research is important. Universities and funding agencies should make improving the situation a priority.
  • The panel encourages funding sufficient to promote the dissemination of violence prevention programs that have been shown to be effective through rigorous randomized controlled trial (RCT) research. Funding must include support for research, and monitoring must continue as these programs are more widely implemented.

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is not specifically stated for each recommendation.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2004 Oct 13-15

GUIDELINE DEVELOPER(S)

National Institutes of Health (NIH) State-of-the-Science Panel - Independent Expert Panel

SOURCE(S) OF FUNDING

United States Government

GUIDELINE COMMITTEE

National Institutes of Health State-of-the-Science Panel

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Panel Members: Robert L. Johnson, M.D., (Panel and Conference, Chairperson), Professor and Chair, Department of Pediatrics, Professor of Psychiatry, Director of Adolescent and Young Adult Medicine, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey; Shrikant I. Bangdiwala, Ph.D., Professor, Collaborative Studies Coordinating Center, Department of Biostatistics and Injury, Prevention Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Michael F. Cataldo, Ph.D., Professor of Behavioral Biology, Departments of Pediatrics and Psychiatry, The Johns Hopkins University, School of Medicine , Director, Department of Behavioral Psychology, Kennedy Krieger Institute, Baltimore, Maryland; J. Virgil Costley, Jr., J.D., Juvenile Court Judge (Retired), Professor of Paralegal Studies and Criminal Justice, Dekalb Technical College, Covington Campus, Covington, Georgia; Angela Diaz, M.D., M.P.H., Professor of Pediatrics and Community Medicine, Mount Sinai School of Medicine, Director, Mount Sinai Adolescent Health Center, Mount Sinai Medical Center, New York, New York; Leon Eisenberg, M.D., Presley Professor of Social Medicine, Professor of Psychiatry, Emeritus, Department of Social Medicine, Harvard Medical School, Boston, Massachusetts; Richard O. Lempert, Ph.D., J.D., Eric Stein Distinguished University Professor of Law and Sociology, University of Michigan, Director, Division of Social and Economic Sciences, National Science Foundation, Arlington, Virginia; Angela Barron McBride, Ph.D., R.N., F.A.A.N., Distinguished Professor Indiana University School of Nursing, Indianapolis, Indiana; Lisa Schwartz, M.D., M.S., Senior Research Associate Veterans Affairs Outcome Group, Associate Professor of Medicine and Community and Family Medicine, Dartmouth Medical School Hanover, New Hampshire, Veterans Affairs Medical Center, White River Junction, Vermont; Freya L. Sonenstein, Ph.D., Professor and Director, Center for Adolescent Health Promotion and Disease Prevention, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; Bonita Stanton, M.D., Schotanus Professor and Chair; Carman and Ann Adams, Department of Pediatrics, Children's Hospital of Michigan, Wayne State University Detroit, Michigan; David T. Takeuchi, Ph.D., Professor, School of Social Work and Department of Sociology; University of Washington, Seattle, Washington; Steven Woloshin, M.D., M.S., Senior Research Associate Veterans Affairs, Outcomes Group, Associate Professor of Medicine and Community and Family Medicine, Dartmouth Medical School, Hanover, New Hampshire, Veterans Affairs Medical Center, White River Junction, Vermont

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

All of the panelists who participated in this conference and contributed to the writing of this statement were identified as having no financial or scientific conflict of interest, and all signed forms attesting to this fact. Unlike the expert speakers who present scientific data at the conference, the individuals invited to participate on National Institutes of Health (NIH) Consensus and State-of-the-Science panels are reviewed prior to selection to assure that they are not proponents of an advocacy position with regard to the topic and are not identified with research that could be used to answer the conference questions.

GUIDELINE STATUS

This is the current release of the guideline.

GUIDELINE AVAILABILITY

Electronic copies: Available from the National Institutes of Health (NIH) Consensus Development Conference Program Web site.

Print copies: Available from the NIH Consensus Development Program Information Center, PO Box 2577, Kensington, MD 20891; Toll free phone (in U.S.), 1-888-NIH-CONSENSUS (1-888-644-2667); autofax (in U.S.), 1-888-NIH-CONSENSUS (1-888-644-2667); e-mail: consensus_statements@mail.nih.gov.

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

None available

NGC STATUS

This summary was completed by ECRI on December 15, 2008.

COPYRIGHT STATEMENT

No copyright restrictions apply.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo